UB-612

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameUB-612
Drug Alias NameUB-612
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPanamaUnited StatesTaiwan +[4] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesUnited Biomedical Inc
China Registration ClassN/A

Develop Information

Active CompaniesAurobindo PharmaVaxxinity Inc
Inactive CompaniesUnited Biomedical Inc
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsCoronavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A